Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 10, 2016 9:42 PM ET

Biotechnology

Company Overview of ISA Pharmaceuticals B.V.

Company Overview

ISA Pharmaceuticals B.V., a biopharmaceutical company, develops therapeutic vaccines for cancer and infectious diseases. It offers HPV-SLP vaccine for the treatment of patients suffering from human Papilloma virus, as well as vaccines against ovarian and colorectal cancer, melanoma, and tuberculosis. The company was founded in 2004 and is based in Leiden, the Netherlands.

Niels Bohrweg 11-13

Leiden,  2333 CA

Netherlands

Founded in 2004

Phone:

31 71 332 2310

Fax:

31 71 332 2311

Key Executives for ISA Pharmaceuticals B.V.

Chief Executive Officer
Chief Medical Officer
Chief Business Development Officer
Age: 47
Business Development Director
Chief Scientific Officer
Compensation as of Fiscal Year 2015.

ISA Pharmaceuticals B.V. Key Developments

ISA Pharmaceuticals Appoints Gerben Moolhuizen as Chief Business Development Officer

ISA Pharmaceuticals B.V. announced that Gerben Moolhuizen has been appointed as the company´s Chief Business Development Officer (CBO). Gerben Moolhuizen has over twenty years of experience in the pharmaceutical and biotechnology industry in various roles covering business development, product development and general management. His experience spans very diverse fields covering a broad array of technical areas (biopharmaceuticals, small molecules, drug delivery, pharmaceutical development and manufacturing, diagnostics, vaccines, generics). Gerben Moolhuizen joins ISA Pharmaceuticals from OctoPlus, where his most recent role was General Manager.

ISA Pharmaceuticals B.V. Presents at 8th Annual Biotech Showcase Investor Conference 2016, Jan-13-2016 02:15 PM

ISA Pharmaceuticals B.V. Presents at 8th Annual Biotech Showcase Investor Conference 2016, Jan-13-2016 02:15 PM. Venue: Parc 55 San Francisco, 55 Cyril Magnin Street, San Francisco, CA 94102, United States.

ISA Pharmaceuticals B.V. Presents at BIO-Europe 2015, Nov-02-2015

ISA Pharmaceuticals B.V. Presents at BIO-Europe 2015, Nov-02-2015 . Venue: Munich, Germany.

Similar Private Companies By Industry

Company Name Region
ModiQuest B.V. Europe
Seghers Genetics and Nutrition NV Europe
Transplant Creations Europe
Check-Points BV Europe
Glaucus Proteomics, B.V. Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact ISA Pharmaceuticals B.V., please visit www.isa-pharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.